07:00 , Sep 26, 2011 |  BC Week In Review  |  Company News

Calypso, Varian Medical Systems deal

Varian will acquire Calypso for about $10 million in cash plus undisclosed milestones based on sales of Calypso products over the next 30 months. Calypso, which markets tumor tracking and motion management products for prostate...
08:00 , Jan 3, 2011 |  BC Week In Review  |  Company News

Celera management update

Celera Corp. (NASDAQ:CRA), Alameda, Calif.   Business: Diagnostic, Pharmacogenetics   Hired: Alfred Merriweather as SVP and CFO, formerly EVP and CFO of Calypso Medical Technologies Inc.  ...
01:12 , Dec 21, 2010 |  BC Extra  |  Company News

Celera names Merriweather CFO

Pharmacogenetics and diagnostics company Celera Corp. (NASDAQ:CRA) hired Alfred Merriweather as SVP and CFO. Merriweather was previously EVP and CFO of Calypso Medical Technologies Inc. (Seattle, Wash.). Celera was off $0.12 to $6.25 on Monday....
07:00 , Sep 21, 2009 |  BC Week In Review  |  Financial News

Calypso completes venture financing

Calypso Medical Technologies Inc. , Seattle, Wash.   Business: Diagnostic   Date completed: 9/17/09   Type: Venture financing   Raised: $50 million   Investors: Skyline Ventures; Frazier Healthcare Ventures; Bay City Capital; InterWest Partners  ...
00:11 , Sep 18, 2009 |  BC Extra  |  Financial News

Calypso Medical raises $50M

Calypso Medical Technologies Inc. (Seattle, Wash.) raised $50 million in a series E round co-led by new investor Skyline Ventures and existing investor Frazier Healthcare Ventures. Existing investor Bay City Capital and new investor InterWest...
02:44 , Dec 10, 2005 |  BC Extra  |  Financial News

BB Biotech closes $123 million fund

BB Biotech closed its BB Biotech Ventures II fund at $123 million. The fund will invest in 10 to 15 North American and European biotech and device companies with clinical stage products. The fund already...